These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 8406655)

  • 1. Feasibility and efficacy of sodium reduction in the Trials of Hypertension Prevention, phase I. Trials of Hypertension Prevention Collaborative Research Group.
    Kumanyika SK; Hebert PR; Cutler JA; Lasser VI; Sugars CP; Steffen-Batey L; Brewer AA; Cameron M; Shepek LD; Cook NR
    Hypertension; 1993 Oct; 22(4):502-12. PubMed ID: 8406655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of longer term modest salt reduction on blood pressure: Cochrane systematic review and meta-analysis of randomised trials.
    He FJ; Li J; Macgregor GA
    BMJ; 2013 Apr; 346():f1325. PubMed ID: 23558162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of weight loss and sodium reduction intervention on blood pressure and hypertension incidence in overweight people with high-normal blood pressure. The Trials of Hypertension Prevention, phase II. The Trials of Hypertension Prevention Collaborative Research Group.
    Arch Intern Med; 1997 Mar; 157(6):657-67. PubMed ID: 9080920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sodium reduction for hypertension prevention in overweight adults: further results from the Trials of Hypertension Prevention Phase II.
    Kumanyika SK; Cook NR; Cutler JA; Belden L; Brewer A; Cohen JD; Hebert PR; Lasser VI; Raines J; Raczynski J; Shepek L; Diller L; Whelton PK; Yamamoto M;
    J Hum Hypertens; 2005 Jan; 19(1):33-45. PubMed ID: 15372064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of dose and duration of reduction in dietary sodium on blood pressure levels: systematic review and meta-analysis of randomised trials.
    Huang L; Trieu K; Yoshimura S; Neal B; Woodward M; Campbell NRC; Li Q; Lackland DT; Leung AA; Anderson CAM; MacGregor GA; He FJ
    BMJ; 2020 Feb; 368():m315. PubMed ID: 32094151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of reduced sodium intake on hypertension control in older individuals: results from the Trial of Nonpharmacologic Interventions in the Elderly (TONE).
    Appel LJ; Espeland MA; Easter L; Wilson AC; Folmar S; Lacy CR
    Arch Intern Med; 2001 Mar; 161(5):685-93. PubMed ID: 11231700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of reduced dietary sodium on blood pressure: a meta-analysis of randomized controlled trials.
    Midgley JP; Matthew AG; Greenwood CM; Logan AG
    JAMA; 1996 May 22-29; 275(20):1590-7. PubMed ID: 8622251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of nonpharmacologic interventions on blood pressure of persons with high normal levels. Results of the Trials of Hypertension Prevention, Phase I.
    JAMA; 1992 Mar; 267(9):1213-20. PubMed ID: 1586398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fatal and nonfatal outcomes, incidence of hypertension, and blood pressure changes in relation to urinary sodium excretion.
    Stolarz-Skrzypek K; Kuznetsova T; Thijs L; Tikhonoff V; Seidlerová J; Richart T; Jin Y; Olszanecka A; Malyutina S; Casiglia E; Filipovský J; Kawecka-Jaszcz K; Nikitin Y; Staessen JA;
    JAMA; 2011 May; 305(17):1777-85. PubMed ID: 21540421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of nonpharmacologic interventions in adults with high-normal blood pressure: results from phase 1 of the Trials of Hypertension Prevention. Trials of Hypertension Prevention Collaborative Research Group.
    Whelton PK; Kumanyika SK; Cook NR; Cutler JA; Borhani NO; Hennekens CH; Kuller LH; Langford H; Jones DW; Satterfield S; Lasser NL; Cohen JD
    Am J Clin Nutr; 1997 Feb; 65(2 Suppl):652S-660S. PubMed ID: 9022561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of a Province-Wide Intervention With Salt Intake and Hypertension in Shandong Province, China, 2011-2016.
    Xu A; Ma J; Guo X; Wang L; Wu J; Zhang J; Bai Y; Xu J; Lu Z; Xu Z; Zhang X; Ding G; Hong Y; Du F; Wu Y; Yan L; Tang J; Cai X; Dong J; Xu C; Ren J; Chen X; Gao C; Zhang B; Yang Q; Moolenaar R; Cai Y; Jackson SL; Xie G; Yu S; Cui J; Wang Z; Zhao L; Ju L; Shen D; Yun S; Liang X; Bi Z; Wang Y
    JAMA Intern Med; 2020 Jun; 180(6):877-886. PubMed ID: 32338717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Moderate dietary sodium restriction added to angiotensin converting enzyme inhibition compared with dual blockade in lowering proteinuria and blood pressure: randomised controlled trial.
    Slagman MC; Waanders F; Hemmelder MH; Woittiez AJ; Janssen WM; Lambers Heerspink HJ; Navis G; Laverman GD;
    BMJ; 2011 Jul; 343():d4366. PubMed ID: 21791491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The feasibility of implementing a dietary sodium reduction intervention among free-living normotensive individuals in south west Nigeria.
    Adeyemo AA; Prewitt TE; Luke A; Omotade OO; Rotimi CN; Brieger WR; Cooper RS
    Ethn Dis; 2002; 12(2):207-12. PubMed ID: 12019929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lifestyle modifications to prevent and control hypertension. 5. Recommendations on dietary salt. Canadian Hypertension Society, Canadian Coalition for High Blood Pressure Prevention and Control, Laboratory Centre for Disease Control at Health Canada, Heart and Stroke Foundation of Canada.
    Fodor JG; Whitmore B; Leenen F; Larochelle P
    CMAJ; 1999 May; 160(9 Suppl):S29-34. PubMed ID: 10333851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Baseline characteristics of participants in phase II of the Trials of Hypertension Prevention (TOHP II). Trials of Hypertension Prevention (TOHP) Collaborative Research Group.
    Appel LJ; Hebert PR; Cohen JD; Obarzanek E; Yamamoto M; Buring J; Stevens V; Kirchner K; Borhani NO
    Ann Epidemiol; 1995 Mar; 5(2):149-55. PubMed ID: 7795833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, methods, and rationale in the Hypertension Prevention Trial. Hypertension Prevention Trial Research Group.
    Meinert CL; Borhani NO; Langford HG
    Control Clin Trials; 1989 Sep; 10(3 Suppl):1S-29S. PubMed ID: 2680271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Hypertension Prevention Trial: three-year effects of dietary changes on blood pressure. Hypertension Prevention Trial Research Group.
    Arch Intern Med; 1990 Jan; 150(1):153-62. PubMed ID: 2404477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trial of stress reduction for hypertension in older African Americans. II. Sex and risk subgroup analysis.
    Alexander CN; Schneider RH; Staggers F; Sheppard W; Clayborne BM; Rainforth M; Salerno J; Kondwani K; Smith S; Walton KG; Egan B
    Hypertension; 1996 Aug; 28(2):228-37. PubMed ID: 8707387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design of a multicenter trial to evaluate long-term life-style intervention in adults with high-normal blood pressure levels. Trials of Hypertension Prevention (phase II). Trials of Hypertension Prevention (TOHP) Collaborative Research Group.
    Hebert PR; Bolt RJ; Borhani NO; Cook NR; Cohen JD; Cutler JA; Hollis JF; Kuller LH; Lasser NL; Oberman A
    Ann Epidemiol; 1995 Mar; 5(2):130-9. PubMed ID: 7795831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of blood pressure effect with calcium and magnesium supplementation in adults with high-normal blood pressure. Results from Phase I of the Trials of Hypertension Prevention (TOHP). Trials of Hypertension Prevention (TOHP) Collaborative Research Group.
    Yamamoto ME; Applegate WB; Klag MJ; Borhani NO; Cohen JD; Kirchner KA; Lakatos E; Sacks FM; Taylor JO; Hennekens CH
    Ann Epidemiol; 1995 Mar; 5(2):96-107. PubMed ID: 7795837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.